Recruiting NCT06595160

Determining the Link Between Dietary Patterns, Fecal Microbiome and Response to Neoadjuvant Chemotherapy

Trial Parameters

Condition Borderline Resectable Pancreatic Ductal Adenocarcinoma

Sponsor Emory University

Study Type OBSERVATIONAL

Phase N/A

Enrollment 87

Sex ALL

Min Age 18 Years

Max Age N/A

Start Date 2024-08-05

Completion 2026-04-30

All Conditions

Borderline Resectable Pancreatic Ductal Adenocarcinoma Resectable Pancreatic Ductal Adenocarcinoma Stage I Pancreatic Cancer AJCC v8

Interventions

Non-Interventional Study

Brief Summary

This study explores the relationship between pre-treatment dietary patterns, fecal microbiome, and response to chemotherapy in patients with pancreatic ductal adenocarcinoma.

Eligibility Criteria

Inclusion Criteria: * \* Age ≥ 18 years with signed informed consent form * Patients must have a histological diagnosis of PDAC * Resectable or borderline resectable PDAC on imaging Exclusion Criteria: * \* Patients with locally advanced and metastatic stage IV PDAC * Patients who have already received or completed neoadjuvant chemotherapy for PDAC * Patients with active malignancy receiving systemic therapy

Related Trials

NCT06595160

Determining the Link Between Dietary Patterns, Fecal Microbiome and Response to Neoadjuvant Chemothe

View Trial →

VIEW ON CLINICALTRIALS.GOV ↗ MORE BORDERLINE RESECTABLE PANCREATIC DUCTAL ADENOCARCINOMA TRIALS